Diamedica Therapeutics Inc. (DMAC)

Market is closed

Sector: Pharmaceutical Preparations

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on December 02, 2025, 3:47pm based on SEC 13F filings Last update: December 02, 2025, 3:47pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Omega Advisors Leon Cooperman	3,269,761	$17,644,158	+99%	0.55%
2.	Millennium Management Israel Englander	1,187,309	$8,156,813		0%
3.	Citadel Investment Group Ken Griffin	69,352	$476,448		0%
4.	Private Capital Management Gregg J. Powers	50,000	$343,500		0.03%
5.	Marshall Wace LLP Paul Marshall And Ian Wace	39,062	$268,356	-37%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Stahlberg Large Shareholder	$8.57	73,099	$626,816.62	8,825,742	2025-11-25	Filing
Stahlberg Large Shareholder	$7.89	40,253	$317,720.95	8,752,643	2025-11-24	Filing
Stahlberg Large Shareholder	$7.41	208,872	$1,547,574.42	8,712,390	2025-11-21	Filing
Stahlberg Large Shareholder	$7.41	128,426	$951,212.85	8,503,518	2025-11-20	Filing
Stahlberg Large Shareholder	$7.21	240,352	$1,732,361.08	8,375,092	2025-11-19	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Von Large Shareholder	$1.24	2,855,847	$3,526,971.05	0	2022-12-02	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Blackrock, Inc.	1,678,139	$11,528,816	0%
2.	Paragon Associates & Paragon Associates Ii Joint Venture	875,000	$6,011,250	10.72%
3.	Geode Capital Management, Llc	711,818	$4,891,114	0%
4.	Vanguard Group Inc	664,575	$4,565,630	0%
5.	Morgan Stanley	579,585	$3,981,749	0%